Gene Symbol | Gene ID | Gene Info |
---|---|---|
Srf
|
ENSMUSG00000015605.5 | serum response factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_46552619_46552770 | Srf | 901 | 0.345886 | -0.09 | 5.0e-01 | Click! |
chr17_46558030_46558181 | Srf | 1930 | 0.194101 | 0.06 | 6.5e-01 | Click! |
chr17_46554762_46555305 | Srf | 1142 | 0.263003 | 0.04 | 7.7e-01 | Click! |
chr17_46556559_46556879 | Srf | 544 | 0.615039 | 0.04 | 7.7e-01 | Click! |
chr17_46549305_46549491 | Srf | 702 | 0.503322 | -0.03 | 8.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_109557850_109558797 | 36.60 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr14_14354416_14355184 | 35.26 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr2_114052677_114053403 | 34.18 |
Actc1 |
actin, alpha, cardiac muscle 1 |
153 |
0.93 |
chr11_86586799_86587209 | 31.92 |
Vmp1 |
vacuole membrane protein 1 |
10 |
0.97 |
chr14_75837044_75838069 | 30.73 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr14_54966561_54966785 | 30.43 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
32 |
0.91 |
chr5_122621646_122621889 | 29.90 |
Ift81 |
intraflagellar transport 81 |
7249 |
0.13 |
chr5_103620180_103620344 | 27.93 |
Gm15844 |
predicted gene 15844 |
4209 |
0.16 |
chr7_112270932_112271230 | 27.08 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
218 |
0.96 |
chr7_44473014_44473571 | 26.84 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
246 |
0.78 |
chr12_86091457_86091777 | 26.79 |
Ift43 |
intraflagellar transport 43 |
505 |
0.74 |
chr7_125764515_125764737 | 26.65 |
D430042O09Rik |
RIKEN cDNA D430042O09 gene |
21629 |
0.21 |
chr6_124919273_124920636 | 26.23 |
Ptms |
parathymosin |
149 |
0.88 |
chr6_127989599_127990020 | 25.14 |
Tspan9 |
tetraspanin 9 |
22992 |
0.16 |
chr16_4497786_4498183 | 24.17 |
Srl |
sarcalumenin |
25079 |
0.14 |
chr14_20768613_20768995 | 23.95 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
3295 |
0.15 |
chr14_26441437_26441768 | 23.94 |
Slmap |
sarcolemma associated protein |
1053 |
0.48 |
chr13_93992771_93993277 | 23.34 |
Gm47216 |
predicted gene, 47216 |
1256 |
0.46 |
chr6_121173620_121173821 | 23.25 |
Pex26 |
peroxisomal biogenesis factor 26 |
9947 |
0.13 |
chr13_46426726_46426905 | 23.14 |
Rbm24 |
RNA binding motif protein 24 |
4993 |
0.26 |
chr18_61652387_61652726 | 22.11 |
Mir143 |
microRNA 143 |
3298 |
0.14 |
chr9_45935889_45936267 | 21.76 |
Tagln |
transgelin |
20 |
0.94 |
chr9_110763394_110763712 | 21.43 |
Myl3 |
myosin, light polypeptide 3 |
93 |
0.95 |
chr1_171263156_171263797 | 21.25 |
B4galt3 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 |
6852 |
0.07 |
chr11_101060276_101060467 | 21.22 |
Naglu |
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) |
9641 |
0.09 |
chr2_163397932_163398257 | 21.04 |
Jph2 |
junctophilin 2 |
101 |
0.95 |
chr16_59587967_59588145 | 20.70 |
Crybg3 |
beta-gamma crystallin domain containing 3 |
12923 |
0.19 |
chr10_86310704_86310867 | 19.74 |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
7931 |
0.24 |
chr5_129415395_129415599 | 19.73 |
Gm43001 |
predicted gene 43001 |
51377 |
0.13 |
chr10_99285899_99286050 | 19.59 |
Gm48089 |
predicted gene, 48089 |
11178 |
0.12 |
chr1_135731863_135732606 | 19.06 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr10_110874957_110875148 | 18.89 |
Gm22186 |
predicted gene, 22186 |
17367 |
0.14 |
chr11_46213918_46214102 | 18.88 |
Fndc9 |
fibronectin type III domain containing 9 |
21521 |
0.12 |
chr17_46555466_46556535 | 18.88 |
Srf |
serum response factor |
175 |
0.9 |
chr4_59898550_59898914 | 18.73 |
Gm12542 |
predicted gene 12542 |
3808 |
0.18 |
chr17_29457852_29458046 | 18.67 |
Gm36199 |
predicted gene, 36199 |
4 |
0.96 |
chr2_120098846_120099211 | 18.64 |
Sptbn5 |
spectrin beta, non-erythrocytic 5 |
13350 |
0.14 |
chr1_118486070_118486397 | 18.64 |
Clasp1 |
CLIP associating protein 1 |
4194 |
0.17 |
chr6_86830698_86830849 | 18.56 |
2610306M01Rik |
RIKEN cDNA 2610306M01 gene |
18667 |
0.12 |
chr9_67049090_67049794 | 18.34 |
Tpm1 |
tropomyosin 1, alpha |
36 |
0.98 |
chr13_110929688_110929864 | 18.32 |
4930526H09Rik |
RIKEN cDNA 4930526H09 gene |
25930 |
0.16 |
chr4_120615850_120616212 | 18.29 |
Gm12860 |
predicted gene 12860 |
191 |
0.93 |
chr12_116326254_116326405 | 18.10 |
Esyt2 |
extended synaptotagmin-like protein 2 |
2153 |
0.26 |
chr3_20145651_20146087 | 18.09 |
Gyg |
glycogenin |
9200 |
0.2 |
chr5_129731131_129731288 | 18.04 |
Gm15903 |
predicted gene 15903 |
3037 |
0.14 |
chr7_112276736_112277133 | 17.95 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
5635 |
0.31 |
chr12_80208587_80208790 | 17.90 |
Gm47767 |
predicted gene, 47767 |
555 |
0.71 |
chr6_30622158_30622633 | 17.76 |
Cpa5 |
carboxypeptidase A5 |
9840 |
0.12 |
chr14_34588575_34588814 | 17.54 |
Ldb3 |
LIM domain binding 3 |
12 |
0.96 |
chr17_35549462_35549916 | 17.47 |
Cdsn |
corneodesmosin |
2439 |
0.12 |
chr17_71019299_71019748 | 17.45 |
Myom1 |
myomesin 1 |
2 |
0.96 |
chr9_118701294_118701445 | 17.38 |
Itga9 |
integrin alpha 9 |
10288 |
0.24 |
chr3_142439642_142439816 | 17.33 |
Pdlim5 |
PDZ and LIM domain 5 |
44033 |
0.13 |
chr2_163392547_163392724 | 17.31 |
Jph2 |
junctophilin 2 |
5314 |
0.15 |
chr4_43558706_43559190 | 17.24 |
Tln1 |
talin 1 |
488 |
0.57 |
chr9_118741385_118741611 | 17.20 |
Itga9 |
integrin alpha 9 |
29841 |
0.19 |
chr5_140765336_140765550 | 17.18 |
Amz1 |
archaelysin family metallopeptidase 1 |
16160 |
0.18 |
chr18_56688485_56688641 | 17.10 |
Lmnb1 |
lamin B1 |
19250 |
0.15 |
chr8_33889104_33889277 | 16.95 |
Rbpms |
RNA binding protein gene with multiple splicing |
592 |
0.71 |
chr16_94721521_94722246 | 16.93 |
Gm41505 |
predicted gene, 41505 |
11 |
0.98 |
chr11_82911086_82911372 | 16.91 |
Unc45b |
unc-45 myosin chaperone B |
24 |
0.94 |
chr15_7189869_7190021 | 16.81 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
33124 |
0.19 |
chr7_110982017_110982316 | 16.72 |
Mrvi1 |
MRV integration site 1 |
38 |
0.98 |
chr7_28945614_28946203 | 16.70 |
Gm44699 |
predicted gene 44699 |
2380 |
0.16 |
chr9_30445503_30445678 | 16.68 |
Snx19 |
sorting nexin 19 |
9733 |
0.2 |
chr7_19410749_19411152 | 16.61 |
Ckm |
creatine kinase, muscle |
75 |
0.92 |
chr16_34269698_34269876 | 16.51 |
Kalrn |
kalirin, RhoGEF kinase |
6587 |
0.33 |
chr2_180393428_180393719 | 16.46 |
Mir1a-1 |
microRNA 1a-1 |
4525 |
0.14 |
chr3_51268535_51268696 | 16.33 |
4930577N17Rik |
RIKEN cDNA 4930577N17 gene |
8144 |
0.12 |
chr17_28344321_28344512 | 16.31 |
Tead3 |
TEA domain family member 3 |
5930 |
0.1 |
chr6_34598135_34598368 | 16.28 |
Cald1 |
caldesmon 1 |
249 |
0.93 |
chr6_38949932_38950131 | 16.26 |
Tbxas1 |
thromboxane A synthase 1, platelet |
8630 |
0.19 |
chr4_57538139_57538356 | 16.21 |
Pakap |
paralemmin A kinase anchor protein |
29912 |
0.2 |
chr15_102017591_102018334 | 16.07 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr6_34722727_34722878 | 15.95 |
Npn2 |
neoplastic progression 2 |
4103 |
0.16 |
chr6_50314414_50314649 | 15.94 |
Osbpl3 |
oxysterol binding protein-like 3 |
14177 |
0.23 |
chr15_77798600_77799338 | 15.94 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
14262 |
0.13 |
chr8_11357901_11358379 | 15.91 |
Col4a1 |
collagen, type IV, alpha 1 |
45314 |
0.1 |
chr8_33905789_33906327 | 15.91 |
Rbpms |
RNA binding protein gene with multiple splicing |
14294 |
0.16 |
chr6_135136423_135136864 | 15.83 |
Gm29803 |
predicted gene, 29803 |
2191 |
0.2 |
chr1_165707942_165708336 | 15.79 |
Rcsd1 |
RCSD domain containing 1 |
53 |
0.95 |
chr15_79097675_79097980 | 15.78 |
Micall1 |
microtubule associated monooxygenase, calponin and LIM domain containing -like 1 |
11071 |
0.08 |
chr9_71589150_71589312 | 15.58 |
Myzap |
myocardial zonula adherens protein |
3034 |
0.26 |
chr14_54996790_54997188 | 15.55 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
2363 |
0.11 |
chrX_159942788_159942962 | 15.30 |
Sh3kbp1 |
SH3-domain kinase binding protein 1 |
37 |
0.98 |
chr8_33837018_33837169 | 15.29 |
Rbpms |
RNA binding protein gene with multiple splicing |
6578 |
0.18 |
chr18_10784306_10784487 | 15.15 |
Mir1b |
microRNA 1b |
1050 |
0.24 |
chr16_34958659_34958990 | 15.15 |
E130310I04Rik |
RIKEN cDNA E130310I04 gene |
54 |
0.97 |
chr18_5186907_5187079 | 15.12 |
Gm26682 |
predicted gene, 26682 |
21262 |
0.24 |
chr17_31889924_31890110 | 14.98 |
Gm50000 |
predicted gene, 50000 |
9161 |
0.14 |
chr15_77037349_77037663 | 14.97 |
Apol6 |
apolipoprotein L 6 |
7223 |
0.11 |
chr12_103355951_103356102 | 14.97 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
25 |
0.96 |
chr15_83535708_83535878 | 14.96 |
Bik |
BCL2-interacting killer |
2249 |
0.18 |
chr7_31054542_31054979 | 14.96 |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
28 |
0.94 |
chr12_80238612_80238914 | 14.95 |
Actn1 |
actinin, alpha 1 |
20021 |
0.13 |
chr7_130668726_130668881 | 14.94 |
4930513N20Rik |
RIKEN cDNA 4930513N20 gene |
14411 |
0.18 |
chr7_128246677_128247053 | 14.92 |
Tgfb1i1 |
transforming growth factor beta 1 induced transcript 1 |
6 |
0.94 |
chr12_111682900_111683107 | 14.90 |
Trmt61a |
tRNA methyltransferase 61A |
4887 |
0.11 |
chr9_65551047_65551511 | 14.87 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
10885 |
0.13 |
chr14_61098125_61098356 | 14.86 |
Gm41168 |
predicted gene, 41168 |
34813 |
0.15 |
chr12_72983608_72983834 | 14.84 |
Gm38170 |
predicted gene, 38170 |
32826 |
0.12 |
chr7_141008925_141009337 | 14.78 |
Ifitm3 |
interferon induced transmembrane protein 3 |
1639 |
0.17 |
chr7_3292788_3293314 | 14.73 |
Myadm |
myeloid-associated differentiation marker |
43 |
0.94 |
chr3_68468044_68468244 | 14.70 |
Schip1 |
schwannomin interacting protein 1 |
39 |
0.98 |
chr19_5725329_5725532 | 14.60 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
840 |
0.29 |
chrX_142833203_142833366 | 14.54 |
Tmem164 |
transmembrane protein 164 |
7543 |
0.24 |
chr11_106762567_106762821 | 14.51 |
Gm25889 |
predicted gene, 25889 |
2047 |
0.17 |
chr19_34254241_34254420 | 14.46 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
100 |
0.96 |
chr14_31209142_31209517 | 14.35 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
997 |
0.35 |
chr13_73299369_73299615 | 14.34 |
Gm10263 |
predicted gene 10263 |
18352 |
0.13 |
chr5_114370337_114370819 | 14.30 |
Kctd10 |
potassium channel tetramerisation domain containing 10 |
371 |
0.81 |
chr4_135286762_135287375 | 14.25 |
Gm12983 |
predicted gene 12983 |
3607 |
0.15 |
chr15_77905362_77905564 | 14.12 |
Txn2 |
thioredoxin 2 |
10237 |
0.15 |
chr11_96303094_96303989 | 14.10 |
Hoxb5 |
homeobox B5 |
29 |
0.92 |
chr7_142578384_142578679 | 14.09 |
H19 |
H19, imprinted maternally expressed transcript |
388 |
0.7 |
chr11_100400946_100401097 | 14.08 |
Gm12348 |
predicted gene 12348 |
487 |
0.58 |
chr11_95402794_95403111 | 14.05 |
Spop |
speckle-type BTB/POZ protein |
11128 |
0.12 |
chr12_111894163_111894488 | 14.03 |
Ppp1r13b |
protein phosphatase 1, regulatory subunit 13B |
13294 |
0.12 |
chr9_71163197_71163362 | 14.01 |
Aqp9 |
aquaporin 9 |
10 |
0.91 |
chr7_28939916_28940069 | 14.01 |
Gm44699 |
predicted gene 44699 |
3536 |
0.13 |
chr10_93441898_93442049 | 13.99 |
Mir7688 |
microRNA 7688 |
8866 |
0.15 |
chr9_95194243_95194423 | 13.98 |
Slc9a9 |
solute carrier family 9 (sodium/hydrogen exchanger), member 9 |
72647 |
0.11 |
chr1_74015930_74016124 | 13.89 |
Tns1 |
tensin 1 |
395 |
0.89 |
chr2_31165014_31165443 | 13.87 |
Gpr107 |
G protein-coupled receptor 107 |
7039 |
0.14 |
chr18_23836208_23836364 | 13.85 |
Gm23207 |
predicted gene, 23207 |
18915 |
0.17 |
chr12_119390165_119390727 | 13.82 |
Macc1 |
metastasis associated in colon cancer 1 |
71 |
0.98 |
chr11_116100521_116100704 | 13.81 |
Trim47 |
tripartite motif-containing 47 |
6471 |
0.1 |
chr2_114046819_114047040 | 13.80 |
Actc1 |
actin, alpha, cardiac muscle 1 |
5958 |
0.17 |
chr5_143055749_143055940 | 13.77 |
Gm43378 |
predicted gene 43378 |
5801 |
0.15 |
chr11_74493283_74493434 | 13.73 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
29393 |
0.16 |
chr10_76590302_76590492 | 13.73 |
Ftcd |
formiminotransferase cyclodeaminase |
3264 |
0.16 |
chr2_118039389_118039713 | 13.62 |
Gm36979 |
predicted gene, 36979 |
292 |
0.91 |
chr1_170605499_170605914 | 13.59 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
15845 |
0.17 |
chr11_88856439_88856852 | 13.56 |
4930556N13Rik |
RIKEN cDNA 4930556N13 gene |
5041 |
0.17 |
chr2_156774838_156775494 | 13.54 |
Myl9 |
myosin, light polypeptide 9, regulatory |
254 |
0.87 |
chr17_25082172_25082487 | 13.53 |
Tmem204 |
transmembrane protein 204 |
1139 |
0.34 |
chr16_24494651_24494847 | 13.53 |
Morf4l1-ps1 |
mortality factor 4 like 1, pseudogene 1 |
34645 |
0.17 |
chr8_103235053_103235264 | 13.52 |
Gm32531 |
predicted gene, 32531 |
36233 |
0.21 |
chr6_94303591_94303742 | 13.45 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
19749 |
0.18 |
chr19_5488788_5489254 | 13.40 |
1700061A03Rik |
RIKEN cDNA 1700061A03 gene |
177 |
0.73 |
chr13_60007626_60007984 | 13.36 |
A530065N20Rik |
RIKEN cDNA A530046M15 gene |
21906 |
0.16 |
chr16_4399932_4400126 | 13.35 |
Adcy9 |
adenylate cyclase 9 |
19558 |
0.19 |
chr10_121429328_121429482 | 13.29 |
Gm18730 |
predicted gene, 18730 |
28692 |
0.1 |
chr2_163353818_163354318 | 13.28 |
Tox2 |
TOX high mobility group box family member 2 |
33690 |
0.12 |
chr9_22100018_22100229 | 13.25 |
Cnn1 |
calponin 1 |
69 |
0.92 |
chr9_24974029_24974488 | 13.19 |
E130101E03Rik |
RIKEN cDNA E130101E03 gene |
50 |
0.97 |
chr3_121340539_121340714 | 13.09 |
Gm5711 |
predicted gene 5711 |
40053 |
0.11 |
chr9_67046108_67046469 | 13.06 |
Tpm1 |
tropomyosin 1, alpha |
2326 |
0.28 |
chr18_33292812_33293223 | 13.03 |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
79155 |
0.1 |
chr5_122320230_122320444 | 12.96 |
Gm15842 |
predicted gene 15842 |
17915 |
0.09 |
chr9_79617333_79617783 | 12.96 |
Col12a1 |
collagen, type XII, alpha 1 |
4588 |
0.24 |
chr5_64156193_64156554 | 12.90 |
Tbc1d1 |
TBC1 domain family, member 1 |
68 |
0.96 |
chr8_10653263_10653664 | 12.88 |
5330413D20Rik |
RIKEN cDNA 5330413D20 gene |
23450 |
0.14 |
chr2_35302031_35302413 | 12.82 |
Stom |
stomatin |
18283 |
0.12 |
chrX_82948673_82948977 | 12.82 |
Dmd |
dystrophin, muscular dystrophy |
45 |
0.99 |
chr6_34608697_34608848 | 12.81 |
Cald1 |
caldesmon 1 |
10152 |
0.19 |
chr18_53607904_53608140 | 12.80 |
Gm19466 |
predicted gene, 19466 |
31084 |
0.21 |
chr18_47241066_47241270 | 12.76 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
40027 |
0.15 |
chr15_79741326_79742933 | 12.73 |
Sun2 |
Sad1 and UNC84 domain containing 2 |
14 |
0.89 |
chr18_61447379_61448092 | 12.69 |
Gm8755 |
predicted gene 8755 |
13534 |
0.12 |
chr10_79988319_79988729 | 12.67 |
Cnn2 |
calponin 2 |
60 |
0.92 |
chr10_122025202_122025630 | 12.51 |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
21892 |
0.15 |
chr17_72275407_72275698 | 12.46 |
Gm19183 |
predicted gene, 19183 |
19294 |
0.28 |
chr2_31953769_31953982 | 12.45 |
Aif1l |
allograft inflammatory factor 1-like |
3358 |
0.15 |
chr14_74846739_74847024 | 12.38 |
Lrch1 |
leucine-rich repeats and calponin homology (CH) domain containing 1 |
38374 |
0.17 |
chr4_43394221_43395099 | 12.34 |
Rusc2 |
RUN and SH3 domain containing 2 |
6578 |
0.14 |
chr1_180185977_180186138 | 12.27 |
Coq8a |
coenzyme Q8A |
3257 |
0.19 |
chr14_34573329_34574596 | 12.26 |
Ldb3 |
LIM domain binding 3 |
3032 |
0.17 |
chr3_79990611_79990765 | 12.23 |
A330069K06Rik |
RIKEN cDNA A330069K06 gene |
64204 |
0.1 |
chr1_170006734_170006907 | 12.22 |
3110045C21Rik |
RIKEN cDNA 3110045C21 gene |
37368 |
0.13 |
chr15_77834324_77834503 | 12.21 |
Gm22107 |
predicted gene, 22107 |
6343 |
0.16 |
chr15_83233410_83233568 | 12.19 |
A4galt |
alpha 1,4-galactosyltransferase |
18240 |
0.12 |
chr15_97102912_97103104 | 12.14 |
Slc38a4 |
solute carrier family 38, member 4 |
47052 |
0.15 |
chr6_70821623_70821846 | 12.08 |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
22781 |
0.13 |
chr2_180230568_180230750 | 12.07 |
Lama5 |
laminin, alpha 5 |
4800 |
0.13 |
chr7_126216987_126217138 | 12.05 |
Xpo6 |
exportin 6 |
16561 |
0.11 |
chr5_143989133_143989415 | 12.03 |
Ccz1 |
CCZ1 vacuolar protein trafficking and biogenesis associated |
3310 |
0.15 |
chr5_112896374_112896556 | 12.00 |
Myo18b |
myosin XVIIIb |
103 |
0.97 |
chr1_192823078_192823550 | 11.99 |
Gm38360 |
predicted gene, 38360 |
2187 |
0.22 |
chr3_96571806_96572214 | 11.95 |
Gm16253 |
predicted gene 16253 |
4974 |
0.08 |
chr1_190952923_190953352 | 11.87 |
Angel2 |
angel homolog 2 |
15885 |
0.11 |
chr13_73842816_73842991 | 11.86 |
Nkd2 |
naked cuticle 2 |
4708 |
0.17 |
chr19_10909412_10909603 | 11.85 |
Zp1 |
zona pellucida glycoprotein 1 |
6791 |
0.1 |
chr8_71381974_71382671 | 11.81 |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
362 |
0.74 |
chr1_162217277_162218166 | 11.80 |
Dnm3os |
dynamin 3, opposite strand |
2 |
0.57 |
chr6_108306443_108306615 | 11.79 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
49725 |
0.16 |
chr4_137467048_137467450 | 11.78 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
1520 |
0.3 |
chr13_53156417_53156599 | 11.78 |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
119150 |
0.05 |
chr18_78267295_78267780 | 11.77 |
Slc14a2 |
solute carrier family 14 (urea transporter), member 2 |
58443 |
0.14 |
chr7_112290032_112290391 | 11.77 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
18912 |
0.26 |
chr15_59759585_59759917 | 11.75 |
Gm19510 |
predicted gene, 19510 |
35208 |
0.19 |
chr14_33244702_33244853 | 11.75 |
Arhgap22 |
Rho GTPase activating protein 22 |
5613 |
0.16 |
chr4_150785275_150785430 | 11.75 |
Gm13049 |
predicted gene 13049 |
40381 |
0.13 |
chr12_52877483_52877640 | 11.71 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
81725 |
0.1 |
chr12_76308094_76308245 | 11.65 |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase |
1103 |
0.28 |
chr11_79113006_79113168 | 11.65 |
Ksr1 |
kinase suppressor of ras 1 |
33320 |
0.16 |
chr1_62579411_62579742 | 11.63 |
Gm29084 |
predicted gene 29084 |
43634 |
0.14 |
chr9_46903783_46904099 | 11.62 |
2900052N01Rik |
RIKEN cDNA 2900052N01 gene |
9552 |
0.24 |
chr11_65650060_65650234 | 11.61 |
Gm26128 |
predicted gene, 26128 |
23753 |
0.21 |
chr7_67031306_67031544 | 11.60 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
16046 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.0 | 71.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
9.0 | 108.5 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
7.4 | 7.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
6.3 | 31.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
5.6 | 22.5 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
5.0 | 15.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
4.8 | 14.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
4.3 | 21.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
4.0 | 12.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.5 | 10.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.1 | 15.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
3.0 | 8.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.8 | 8.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
2.8 | 8.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.7 | 10.9 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
2.7 | 8.1 | GO:0060435 | bronchiole development(GO:0060435) |
2.6 | 13.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
2.6 | 7.8 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.6 | 7.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.5 | 15.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.5 | 10.0 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
2.5 | 24.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
2.4 | 16.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
2.4 | 11.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
2.3 | 9.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
2.2 | 22.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
2.2 | 10.9 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
2.1 | 4.2 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
2.1 | 4.1 | GO:0003166 | bundle of His development(GO:0003166) |
2.0 | 4.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.0 | 6.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
2.0 | 21.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.0 | 11.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.0 | 11.8 | GO:0015671 | oxygen transport(GO:0015671) |
2.0 | 21.6 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
2.0 | 5.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.9 | 5.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.9 | 11.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.8 | 7.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.8 | 1.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.7 | 5.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.7 | 13.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.7 | 11.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.7 | 11.9 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.7 | 5.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.7 | 45.5 | GO:0045214 | sarcomere organization(GO:0045214) |
1.6 | 1.6 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.6 | 3.2 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.5 | 4.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.5 | 4.5 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
1.5 | 7.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.5 | 4.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.5 | 2.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.5 | 4.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.4 | 7.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.4 | 5.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.4 | 12.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.4 | 6.9 | GO:0006116 | NADH oxidation(GO:0006116) |
1.4 | 4.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.3 | 6.7 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.3 | 12.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.3 | 6.6 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
1.3 | 2.6 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
1.3 | 29.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.3 | 5.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.3 | 6.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.3 | 16.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.3 | 7.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.3 | 3.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.3 | 5.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.3 | 3.8 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.2 | 6.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.2 | 3.7 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.2 | 9.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
1.2 | 4.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.2 | 4.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.2 | 1.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.2 | 3.6 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.2 | 3.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.2 | 3.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.2 | 1.2 | GO:0050904 | diapedesis(GO:0050904) |
1.2 | 3.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
1.2 | 2.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.1 | 1.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.1 | 3.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.1 | 5.7 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
1.1 | 14.5 | GO:0001553 | luteinization(GO:0001553) |
1.1 | 17.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.1 | 2.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.1 | 2.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
1.1 | 3.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.1 | 9.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.1 | 9.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.1 | 3.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.0 | 5.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.0 | 6.3 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.0 | 3.1 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.0 | 3.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.0 | 4.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.0 | 3.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.0 | 3.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.0 | 5.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.0 | 3.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.0 | 2.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.0 | 4.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.0 | 13.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
1.0 | 14.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.0 | 6.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.0 | 3.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.0 | 3.9 | GO:0030091 | protein repair(GO:0030091) |
1.0 | 1.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.0 | 2.9 | GO:0071316 | cellular response to nicotine(GO:0071316) |
1.0 | 1.9 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.0 | 2.9 | GO:1902075 | cellular response to salt(GO:1902075) |
1.0 | 3.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.0 | 2.9 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.0 | 10.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.0 | 1.9 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.9 | 3.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.9 | 34.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.9 | 5.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.9 | 2.8 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.9 | 2.8 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.9 | 3.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.9 | 2.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.9 | 0.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.9 | 16.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.9 | 7.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.9 | 5.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.9 | 1.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.9 | 0.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.9 | 9.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.9 | 5.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.9 | 2.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.9 | 4.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.9 | 2.6 | GO:0046909 | intermembrane transport(GO:0046909) |
0.9 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.9 | 6.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.9 | 0.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.9 | 3.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.8 | 2.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.8 | 2.5 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.8 | 6.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.8 | 4.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.8 | 1.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.8 | 4.2 | GO:0006547 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.8 | 3.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.8 | 2.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 0.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.8 | 1.6 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.8 | 1.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.8 | 2.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.8 | 2.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.8 | 21.4 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.8 | 12.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.8 | 4.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.8 | 3.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.8 | 3.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.8 | 3.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.8 | 3.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.8 | 3.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.8 | 1.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.8 | 4.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 2.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 1.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.7 | 1.5 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.7 | 1.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.7 | 3.7 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.7 | 2.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 0.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.7 | 2.2 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.7 | 2.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 2.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.7 | 22.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.7 | 2.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.7 | 2.2 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.7 | 1.4 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.7 | 2.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.7 | 8.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 2.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 2.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.7 | 2.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 2.1 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.7 | 6.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 2.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.7 | 2.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 2.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.7 | 2.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 7.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.7 | 6.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 1.4 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.7 | 2.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.7 | 1.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 3.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.7 | 22.3 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.7 | 2.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 2.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.7 | 11.7 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.7 | 10.3 | GO:0033622 | integrin activation(GO:0033622) |
0.7 | 0.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.7 | 8.9 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.7 | 3.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.7 | 2.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 | 2.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 37.1 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.7 | 1.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.7 | 16.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.7 | 0.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 5.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.7 | 3.4 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.7 | 1.3 | GO:0071440 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) |
0.7 | 5.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.7 | 2.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.7 | 5.2 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.7 | 2.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.7 | 0.7 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.7 | 0.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 1.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.7 | 2.6 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.7 | 1.3 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.7 | 2.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.7 | 2.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.6 | 1.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.6 | 0.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 0.6 | GO:0070836 | caveola assembly(GO:0070836) |
0.6 | 2.6 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.6 | 1.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 28.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.6 | 1.9 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.6 | 1.9 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.6 | 1.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.6 | 5.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 1.9 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.6 | 1.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 2.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.6 | 2.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.6 | 0.6 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.6 | 0.6 | GO:0015840 | urea transport(GO:0015840) |
0.6 | 1.9 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 0.6 | GO:0042119 | neutrophil activation(GO:0042119) |
0.6 | 1.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 3.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 1.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 3.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 1.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.6 | 9.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.6 | 3.0 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.6 | 3.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.6 | 1.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.6 | 6.7 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.6 | 1.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.6 | 3.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 2.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.6 | 4.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.6 | 2.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 23.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.6 | 5.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.6 | 1.1 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 2.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.6 | 10.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.6 | 2.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.6 | 1.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.6 | 1.7 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 5.0 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.6 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 1.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.6 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.6 | 3.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.5 | 1.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.5 | 1.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 2.7 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.5 | 1.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.5 | 4.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 5.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 0.5 | GO:0072033 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.5 | 1.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 2.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.5 | 2.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 2.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 1.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 3.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.5 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 2.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 2.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 1.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.5 | 2.0 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 1.0 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.5 | 1.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.5 | 0.5 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.5 | 2.5 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.5 | 6.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.5 | 3.0 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.5 | 1.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.5 | 1.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 0.5 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.5 | 2.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 3.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 2.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.5 | 4.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.5 | 3.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.5 | 3.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 1.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 1.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 4.9 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.5 | 3.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 2.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 2.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 2.4 | GO:0030220 | platelet formation(GO:0030220) |
0.5 | 1.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.5 | 5.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.5 | 4.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 1.4 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.5 | 1.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 0.5 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.5 | 0.9 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.5 | 3.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.5 | 7.6 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.5 | 1.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.5 | 0.9 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.5 | 1.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 1.4 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.5 | 0.9 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 1.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 0.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.5 | 1.9 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 3.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.5 | 0.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.5 | 2.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 1.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 1.4 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.5 | 2.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 1.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 2.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 4.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.5 | 4.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 1.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 0.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 1.3 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.4 | 1.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 2.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 7.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.4 | 1.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 0.9 | GO:1990123 | amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.4 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.4 | 0.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 0.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.4 | 1.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 0.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.4 | 3.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 1.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 0.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 0.9 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 4.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 0.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 4.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.4 | 2.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 0.8 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.4 | 0.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 4.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.4 | 2.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.4 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 0.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 0.8 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.4 | 5.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 1.7 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 5.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 0.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 1.6 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.4 | 7.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 1.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.4 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.4 | 1.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) centrosome separation(GO:0051299) |
0.4 | 0.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 4.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 1.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 1.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 1.2 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 0.4 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.4 | 0.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 2.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 1.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.4 | 2.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 1.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 2.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 2.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 0.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 3.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.4 | 0.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 1.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 2.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.4 | 1.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.4 | 1.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.4 | 2.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 11.3 | GO:0035690 | cellular response to drug(GO:0035690) |
0.4 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 1.9 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.4 | 5.8 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.4 | 1.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 0.4 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 2.7 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.4 | 1.5 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.4 | 1.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 0.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 1.5 | GO:0001840 | neural plate development(GO:0001840) |
0.4 | 4.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.4 | 1.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 0.8 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.4 | 2.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 1.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.4 | 1.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 0.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.4 | 0.4 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 0.4 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.4 | 11.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.4 | 1.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 33.8 | GO:0006936 | muscle contraction(GO:0006936) |
0.4 | 1.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.4 | 8.6 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.4 | 1.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 8.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.4 | 2.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 1.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 6.3 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.4 | 1.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 0.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 0.7 | GO:0032898 | neurotrophin production(GO:0032898) |
0.4 | 0.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 1.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.4 | 5.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 1.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.4 | 0.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.4 | 0.7 | GO:0006971 | hypotonic response(GO:0006971) |
0.4 | 0.7 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.4 | 2.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.4 | 1.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 0.7 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.4 | 2.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 0.4 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.4 | 0.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.4 | 1.8 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 11.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.4 | 1.1 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.4 | 2.5 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.4 | 2.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 2.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.4 | 1.8 | GO:0030730 | regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
0.4 | 1.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 4.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 0.7 | GO:0014002 | astrocyte development(GO:0014002) |
0.4 | 0.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 0.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 1.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 2.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 3.8 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.3 | 2.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 1.7 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.3 | 1.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 2.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 2.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 1.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.3 | 1.7 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 3.4 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.3 | 0.7 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.3 | 2.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.3 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 4.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 | 0.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 1.0 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.3 | 1.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.3 | 0.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 7.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 0.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 2.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.3 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.3 | 2.0 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.3 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 1.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 1.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.3 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 1.3 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.3 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.0 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.6 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.3 | 11.3 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
0.3 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 3.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 0.6 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.3 | 1.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 0.3 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.3 | 1.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 8.5 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.3 | 0.3 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.3 | 1.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 0.9 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 0.3 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 0.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 1.5 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 7.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.3 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 1.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 0.9 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 3.0 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 4.8 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.3 | 0.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 1.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 1.8 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 0.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.3 | 3.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 0.6 | GO:0036230 | granulocyte activation(GO:0036230) |
0.3 | 0.9 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.3 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 1.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 11.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.6 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 0.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.3 | 1.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.9 | GO:0000237 | leptotene(GO:0000237) |
0.3 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 1.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 1.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.4 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
0.3 | 1.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 3.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.3 | 0.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 5.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.3 | 0.3 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.3 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 1.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 0.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 0.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.3 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.3 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 0.6 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 0.6 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.3 | 0.8 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.3 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 3.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 0.6 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.3 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.6 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.3 | 1.4 | GO:1900182 | positive regulation of protein localization to nucleus(GO:1900182) |
0.3 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 0.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 0.5 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 0.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 2.2 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.3 | 0.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 0.8 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.3 | 1.6 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 2.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.3 | 0.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 1.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 11.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.3 | 1.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 0.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 0.8 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 2.9 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 2.3 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.3 | 0.3 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.3 | 0.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.3 | 1.3 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.3 | 0.8 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.3 | 2.6 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 0.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 3.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 1.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.3 | 0.8 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.3 | 1.8 | GO:0061217 | regulation of mesonephros development(GO:0061217) |
0.3 | 2.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 1.0 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.2 | 1.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.2 | 0.2 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.2 | 0.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.5 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 1.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 5.2 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.2 | 0.2 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.2 | 1.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.7 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.2 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 1.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 1.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 0.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 1.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 1.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 0.7 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.2 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 2.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 1.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 1.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 2.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 1.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 0.7 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 1.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.9 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 2.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.7 | GO:0070255 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.2 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.2 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.2 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.2 | 4.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.2 | 1.6 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.2 | 2.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.2 | 0.2 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 0.9 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 3.7 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 1.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 0.2 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.2 | 0.9 | GO:0046456 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.2 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 1.8 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.9 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.2 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.2 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.7 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 0.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 1.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.9 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 7.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 0.4 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 3.7 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.2 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 2.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.2 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.2 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.9 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 1.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 2.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 1.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.2 | 1.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 2.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.2 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.2 | 0.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.2 | 2.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 1.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 1.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 0.2 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.2 | 2.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.6 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 2.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.4 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.2 | 0.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 4.0 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.2 | 0.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 1.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:2000741 | regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.0 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.4 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 1.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 1.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 2.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.2 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.2 | 0.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.6 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.8 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.8 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 4.8 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 1.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 1.3 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.2 | 1.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.2 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.2 | 0.4 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 2.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.4 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.2 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 2.3 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.2 | 0.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.2 | 0.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 1.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.4 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.5 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.2 | 0.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.2 | 2.1 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.2 | 0.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 1.6 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.2 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.4 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 2.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.2 | 0.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.2 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 1.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 0.5 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 1.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.5 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.2 | 0.3 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
0.2 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.7 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.3 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.2 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 3.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 1.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 3.5 | GO:0032608 | interferon-beta production(GO:0032608) |
0.2 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.2 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.2 | 6.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 1.3 | GO:0032400 | melanosome localization(GO:0032400) |
0.2 | 3.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.6 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.2 | 0.9 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.2 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.5 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.2 | 2.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 0.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 1.7 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.2 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 1.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 1.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 5.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 2.9 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.2 | 0.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.2 | 0.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 1.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 1.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.3 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 7.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.4 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 1.0 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 7.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 1.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.3 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 3.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.6 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.4 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 1.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 3.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 2.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 1.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.3 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 1.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.4 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 1.0 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 6.9 | GO:0006906 | vesicle fusion(GO:0006906) |
0.1 | 0.5 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.7 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.3 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 1.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 3.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 1.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 1.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 1.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.3 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 2.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.9 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.1 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.1 | 0.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 3.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:0051029 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.1 | 0.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.9 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.1 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.1 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 1.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.5 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.6 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.8 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.6 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.7 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.1 | 0.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.5 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 1.0 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.4 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 1.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.6 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.5 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 1.5 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 0.1 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.2 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 1.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 1.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 1.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 1.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.6 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 1.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.5 | GO:0019229 | regulation of vasoconstriction(GO:0019229) |
0.1 | 0.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 1.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.3 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.8 | GO:0097352 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.1 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 1.6 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.2 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 2.5 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 1.1 | GO:0042181 | ketone biosynthetic process(GO:0042181) |
0.1 | 0.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 1.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:1902774 | lysosomal membrane organization(GO:0097212) late endosome to lysosome transport(GO:1902774) |
0.1 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.2 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 1.0 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.2 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.3 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.3 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.2 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.3 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 0.8 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.9 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.2 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.1 | 0.6 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 1.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.2 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.1 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.7 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.1 | 0.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 1.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 2.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 3.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.1 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.1 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.3 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.7 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.4 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 1.0 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.3 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.1 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.1 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.9 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 0.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0085020 | protein K27-linked ubiquitination(GO:0044314) protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.1 | GO:0045620 | negative regulation of T cell differentiation(GO:0045581) negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 0.4 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 1.0 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.1 | 0.4 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
0.1 | 0.3 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.1 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.9 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 2.8 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.1 | 0.1 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.7 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.1 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 1.6 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.2 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.2 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 2.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.1 | 0.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.4 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 1.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.2 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.2 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.2 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.3 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.0 | GO:0034661 | rRNA catabolic process(GO:0016075) ncRNA catabolic process(GO:0034661) |
0.0 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.0 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.2 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.0 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.0 | 1.0 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.7 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.0 | 0.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.1 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.0 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.0 | 0.2 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.3 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.1 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.2 | GO:0034397 | telomere localization(GO:0034397) |
0.0 | 0.0 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.1 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 1.2 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.2 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.0 | 0.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.2 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.0 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.0 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.0 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.6 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.0 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
0.0 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 0.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.0 | 0.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.0 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.0 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0051645 | Golgi localization(GO:0051645) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.0 | GO:2000348 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0019692 | 2'-deoxyribonucleotide metabolic process(GO:0009394) deoxyribose phosphate metabolic process(GO:0019692) |
0.0 | 0.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.1 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.0 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0032635 | interleukin-6 production(GO:0032635) |
0.0 | 2.2 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
0.0 | 0.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0030100 | regulation of endocytosis(GO:0030100) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 23.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
6.0 | 23.9 | GO:0030478 | actin cap(GO:0030478) |
5.5 | 49.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
5.3 | 21.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
4.6 | 13.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
4.0 | 31.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.8 | 19.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
3.2 | 9.7 | GO:0097513 | myosin II filament(GO:0097513) |
3.1 | 59.2 | GO:0043034 | costamere(GO:0043034) |
2.9 | 35.2 | GO:0031430 | M band(GO:0031430) |
2.8 | 14.0 | GO:0016460 | myosin II complex(GO:0016460) |
2.8 | 61.6 | GO:0036379 | myofilament(GO:0036379) |
2.7 | 21.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.2 | 17.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.2 | 34.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.1 | 36.0 | GO:0031672 | A band(GO:0031672) |
2.1 | 12.4 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
2.0 | 4.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
2.0 | 106.4 | GO:0042641 | actomyosin(GO:0042641) |
2.0 | 5.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.0 | 5.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.8 | 7.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.7 | 11.6 | GO:0005844 | polysome(GO:0005844) |
1.6 | 1.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.4 | 4.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.3 | 9.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.3 | 1.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.2 | 4.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.2 | 6.1 | GO:0030056 | hemidesmosome(GO:0030056) |
1.2 | 4.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.2 | 6.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.2 | 3.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.1 | 2.3 | GO:0032432 | actin filament bundle(GO:0032432) |
1.1 | 4.2 | GO:0045298 | tubulin complex(GO:0045298) |
1.0 | 10.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
1.0 | 2.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.0 | 5.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.9 | 1.8 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 3.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.9 | 10.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.9 | 1.7 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 6.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.8 | 5.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.8 | 32.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.8 | 0.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.8 | 4.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.8 | 56.4 | GO:0031674 | I band(GO:0031674) |
0.8 | 10.3 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 5.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.8 | 0.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.8 | 4.7 | GO:0016342 | catenin complex(GO:0016342) |
0.8 | 4.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 3.7 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 2.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 0.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.7 | 2.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 3.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.7 | 2.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.7 | 2.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 7.5 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 2.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 3.4 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 59.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.7 | 4.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.7 | 2.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 3.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 5.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.6 | 1.9 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 5.6 | GO:0002102 | podosome(GO:0002102) |
0.6 | 3.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 0.6 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.6 | 2.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 4.7 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 5.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.6 | 4.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 6.3 | GO:0005605 | basal lamina(GO:0005605) |
0.6 | 2.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.6 | 3.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.6 | 2.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 1.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 1.6 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 8.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 2.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 2.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 1.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 5.9 | GO:0042627 | chylomicron(GO:0042627) |
0.5 | 28.1 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 1.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 1.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 5.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.5 | 4.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 3.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 1.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 1.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 14.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 16.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.4 | 2.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 3.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 9.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 9.3 | GO:0030016 | myofibril(GO:0030016) |
0.4 | 0.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 5.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 9.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 3.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 2.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 1.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 3.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 0.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.4 | 0.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.4 | 2.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 2.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 3.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 3.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 3.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 6.1 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 2.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 91.6 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.4 | 2.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 10.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 1.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 3.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 2.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 5.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 4.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 2.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 5.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 3.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 3.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 5.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 2.0 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 0.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 25.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 3.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 11.5 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 2.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 0.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 1.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 0.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 0.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 10.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 0.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 3.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 2.7 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 4.4 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 2.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 3.0 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 1.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 20.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.0 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 1.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 3.4 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 2.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 2.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 3.5 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 1.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 4.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 1.5 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 2.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 6.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 2.4 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.2 | 0.9 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 4.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 11.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 1.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 47.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 7.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 1.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 2.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 6.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 0.6 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 3.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 2.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 1.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 6.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 10.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 8.9 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 1.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 2.2 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 4.6 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 3.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.2 | 16.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.8 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 20.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.2 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 2.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 6.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 3.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.8 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 2.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 41.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 1.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 3.0 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 13.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 2.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 3.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 8.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 2.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.9 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 3.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.5 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.4 | GO:0002141 | stereocilia ankle link(GO:0002141) |
0.1 | 24.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 4.3 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 1.3 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.8 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 6.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 1.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 1.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 2.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 12.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 4.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.8 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.3 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.6 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 4.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.7 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 3.6 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 9.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 2.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 2.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.6 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.8 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 3.5 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 2.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 1.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 130.5 | GO:0044421 | extracellular region part(GO:0044421) |
0.1 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.1 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 16.2 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.1 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 6.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.8 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 1.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 3.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.0 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.0 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 29.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 7.0 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 83.6 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 14.6 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 2.7 | GO:0097708 | intracellular vesicle(GO:0097708) |
0.0 | 6.0 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.8 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.0 | GO:0002177 | manchette(GO:0002177) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 29.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
6.6 | 46.3 | GO:0043731 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
4.6 | 13.8 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
4.2 | 16.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
4.0 | 20.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
3.6 | 28.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
3.2 | 35.4 | GO:0017166 | vinculin binding(GO:0017166) |
3.1 | 9.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.9 | 31.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.8 | 8.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.8 | 16.7 | GO:0048495 | Roundabout binding(GO:0048495) |
2.6 | 23.8 | GO:0031432 | titin binding(GO:0031432) |
2.5 | 7.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.5 | 7.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.3 | 4.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
2.3 | 11.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
2.0 | 8.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.0 | 11.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.9 | 5.6 | GO:0008142 | oxysterol binding(GO:0008142) |
1.8 | 5.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.8 | 20.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.8 | 12.8 | GO:0043495 | protein anchor(GO:0043495) |
1.8 | 14.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.8 | 7.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.8 | 7.1 | GO:0031013 | troponin I binding(GO:0031013) |
1.8 | 14.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.7 | 20.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.7 | 6.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.6 | 11.2 | GO:0030957 | Tat protein binding(GO:0030957) |
1.6 | 6.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.5 | 1.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.5 | 3.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.5 | 28.7 | GO:0003785 | actin monomer binding(GO:0003785) |
1.5 | 4.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.4 | 8.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.4 | 8.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.4 | 4.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.3 | 4.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.3 | 10.7 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
1.3 | 4.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.3 | 61.7 | GO:0017022 | myosin binding(GO:0017022) |
1.3 | 6.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.2 | 5.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.2 | 4.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.2 | 1.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.2 | 19.4 | GO:0008143 | poly(A) binding(GO:0008143) |
1.2 | 2.4 | GO:0031433 | telethonin binding(GO:0031433) |
1.2 | 62.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.2 | 8.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.1 | 12.5 | GO:0031005 | filamin binding(GO:0031005) |
1.1 | 10.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.1 | 4.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.1 | 3.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.1 | 3.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.1 | 16.3 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 5.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.0 | 6.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.0 | 3.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.0 | 6.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.0 | 3.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.0 | 3.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.0 | 3.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 8.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.0 | 2.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.0 | 13.6 | GO:0005542 | folic acid binding(GO:0005542) |
1.0 | 2.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.0 | 2.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.0 | 3.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.9 | 2.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.9 | 6.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.9 | 3.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.9 | 3.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.9 | 1.8 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.9 | 2.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.9 | 9.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.9 | 2.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.9 | 5.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.9 | 4.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.8 | 2.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.8 | 3.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 2.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 2.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.8 | 10.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.8 | 13.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.8 | 3.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.8 | 5.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 16.3 | GO:0042805 | actinin binding(GO:0042805) |
0.8 | 3.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.8 | 5.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.8 | 2.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.8 | 6.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 1.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 2.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.8 | 1.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.7 | 5.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.7 | 2.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.7 | 22.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.7 | 2.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.7 | 2.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.7 | 2.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.7 | 2.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.7 | 1.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 5.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.7 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 2.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 2.1 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 2.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 7.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.7 | 0.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.7 | 55.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.7 | 2.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.7 | 3.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 2.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.6 | 10.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 1.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 10.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 0.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.6 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.6 | 4.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 14.7 | GO:0043236 | laminin binding(GO:0043236) |
0.6 | 1.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.6 | 1.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 4.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 3.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 1.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.6 | 1.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 4.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.6 | 4.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 2.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.6 | 2.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 5.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.6 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 2.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 1.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 2.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 1.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 5.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 2.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 2.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 7.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 2.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 6.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 2.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 1.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 6.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.5 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 1.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 2.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 3.5 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 2.5 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.5 | 2.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 1.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 85.9 | GO:0003779 | actin binding(GO:0003779) |
0.5 | 1.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 4.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.5 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 2.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 1.9 | GO:0009374 | biotin binding(GO:0009374) |
0.5 | 5.7 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 7.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.5 | 1.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 0.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.5 | 16.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.5 | 40.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.5 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 4.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 7.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.5 | 7.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 4.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 1.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 3.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 5.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 3.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 0.9 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.4 | 1.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 3.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 1.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 1.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 9.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 2.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 1.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 2.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 2.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 2.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 2.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 5.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 1.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 1.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 1.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 3.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 5.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 1.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 11.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.4 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 0.4 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.4 | 10.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 3.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 3.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 1.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 1.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 5.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 1.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 1.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 1.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 7.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 3.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 4.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 1.0 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 3.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.3 | 2.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 3.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 1.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 3.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 26.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.3 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 0.7 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 1.3 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 7.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 1.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 2.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 2.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 2.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 1.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 10.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 5.6 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 2.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 3.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 5.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 5.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 2.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 2.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 1.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 1.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 22.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.3 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.5 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 3.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 4.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 5.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 1.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 8.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 3.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 2.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 9.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 2.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 1.6 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 3.1 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 1.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 1.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 2.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.3 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 5.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 7.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.3 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 4.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 2.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 3.0 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.2 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 2.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.7 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.2 | 6.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 2.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 7.3 | GO:0032934 | sterol binding(GO:0032934) |
0.2 | 1.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 1.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 12.9 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.6 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 5.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.9 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 4.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.9 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 0.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 2.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 3.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.7 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 7.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 2.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 3.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 1.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.9 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 1.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 3.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 13.3 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.2 | 1.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 2.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 1.7 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 2.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 1.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 1.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 7.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 1.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 6.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 1.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.2 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 2.7 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 15.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 4.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 30.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 4.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 7.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 2.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 1.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 4.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.2 | 1.4 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 2.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 1.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 34.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 0.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 1.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 0.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 3.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 1.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 2.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 2.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 4.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 2.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.3 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 2.3 | GO:0019838 | growth factor binding(GO:0019838) |
0.2 | 0.6 | GO:0102345 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 1.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.6 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 4.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 1.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.3 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0018573 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 1.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 4.4 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 1.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.4 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 2.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 3.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 1.3 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.9 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 3.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 1.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 2.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 26.9 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.1 | 0.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 9.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 1.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 2.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.5 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 2.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.8 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.2 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 4.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.5 | GO:0034912 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.3 | GO:0015093 | iron ion transmembrane transporter activity(GO:0005381) ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.9 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 1.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 2.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 1.2 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 2.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 1.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 2.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 5.4 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 1.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 1.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 7.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 6.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.7 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 3.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 2.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.1 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 6.8 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0035586 | G-protein coupled adenosine receptor activity(GO:0001609) purinergic receptor activity(GO:0035586) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 1.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 2.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 1.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 1.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 2.2 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 1.1 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 2.3 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 5.3 | GO:0004672 | protein kinase activity(GO:0004672) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 2.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 1.6 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 11.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.4 | 81.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.4 | 4.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.0 | 41.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.9 | 8.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.9 | 20.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.9 | 9.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 31.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.9 | 16.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.8 | 8.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.8 | 11.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.8 | 23.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 22.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.7 | 11.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.7 | 6.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 5.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.7 | 15.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 12.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.7 | 71.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.7 | 15.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.7 | 29.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.6 | 9.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 3.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 3.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 5.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 24.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 20.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 7.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 2.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 4.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 4.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 4.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 6.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 11.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 9.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 10.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 2.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 5.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 6.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 11.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 17.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 4.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 7.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 6.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 3.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 1.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 5.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 3.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 8.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 4.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 2.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 2.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 2.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 2.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 2.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 3.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 7.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 1.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 2.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 9.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 33.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 4.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 32.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 7.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 2.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 2.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 1.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 1.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 4.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 5.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 36.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 4.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 0.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 4.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 3.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 2.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 132.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
4.0 | 91.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
2.0 | 25.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.3 | 13.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.3 | 18.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.1 | 8.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.1 | 20.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.0 | 9.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.8 | 19.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.8 | 18.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.8 | 15.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.8 | 6.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.8 | 12.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.8 | 8.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 0.7 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.7 | 28.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.7 | 7.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 9.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 4.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.7 | 1.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.7 | 10.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 14.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 13.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.6 | 12.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 6.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 2.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 7.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 4.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 5.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 5.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.5 | 7.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.5 | 13.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.5 | 3.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 8.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 1.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.5 | 7.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 18.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 4.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 1.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 11.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.5 | 5.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 28.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 5.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 8.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.5 | 4.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 3.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 3.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 2.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 5.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 5.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 4.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.4 | 1.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 3.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 10.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 6.8 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.4 | 6.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 3.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 5.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 4.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 6.9 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.4 | 10.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 5.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 4.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 2.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 3.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 2.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 2.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 2.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 21.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 2.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 2.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 3.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 4.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 1.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 2.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 5.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 4.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 7.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 4.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 1.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 0.6 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.3 | 2.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 2.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 4.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 1.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 5.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 1.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 2.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 1.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 1.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 2.2 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 3.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 9.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 0.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 3.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 3.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 1.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 2.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 5.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 8.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 4.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 2.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 3.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 10.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 2.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 1.0 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 2.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 6.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 4.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 1.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 6.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 2.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 20.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.6 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 1.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 3.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 6.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 4.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.0 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.1 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 8.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 2.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.2 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |